|
C2ORF76 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.782800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.415700E-04 |
| Normal-vs-Stage2 |
9.360200E-02 |
| Normal-vs-Stage3 |
1.697920E-02 |
| Normal-vs-Stage4 |
5.482500E-03 |
| Stage1-vs-Stage2 |
4.335000E-01 |
| Stage1-vs-Stage3 |
6.092600E-01 |
| Stage1-vs-Stage4 |
9.209800E-01 |
| Stage2-vs-Stage3 |
7.459800E-01 |
| Stage2-vs-Stage4 |
4.840600E-01 |
| Stage3-vs-Stage4 |
6.236000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.481370E-03 |
| Normal-vs-AfricanAmerican |
1.920360E-03 |
| Normal-vs-Asian |
9.998800E-01 |
| Caucasian-vs-AfricanAmerican |
3.424600E-01 |
| Caucasian-vs-Asian |
2.466400E-01 |
| AfricanAmerican-vs-Asian |
7.049600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.972800E-04 |
| Normal-vs-Female |
6.663500E-03 |
| Male-vs-Female |
4.579200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.222600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.420500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.479600E-03 |
| Normal-vs-Age(81-100Yrs) |
4.588400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.988000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.076200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.940200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.031200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.998600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.369000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.955130E-03 |
| Normal-vs-Grade 2 |
1.309930E-02 |
| Normal-vs-Grade 3 |
1.496940E-03 |
| Normal-vs-Grade 4 |
3.217300E-03 |
| Grade 1-vs-Grade 2 |
1.798970E-01 |
| Grade 1-vs-Grade 3 |
2.640800E-01 |
| Grade 1-vs-Grade 4 |
2.180600E-01 |
| Grade 2-vs-Grade 3 |
3.805400E-01 |
| Grade 2-vs-Grade 4 |
3.104600E-01 |
| Grade 3-vs-Grade 4 |
8.021200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.896900E-03 |
| Normal-vs-ccB subtype |
2.835800E-02 |
| ccA subtype-vs-ccB subtype |
4.905600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.057500E-03 |
| Normal-vs-N1 |
2.568000E-01 |
| N0-vs-N1 |
7.141000E-01 |
|
|
